In conclusion, our study establishes a proteomic and transcriptomic map of human HF tissues, highlights the functional importance of GSTM2 in HF progression, and elucidates potential new targets for treatment of cardiac hypertrophy and HF. Here, GSTM2 is linked to cardiac hypertrophy.